As evidence accumulates, underwriting approaches must evolve to recognize improvements while maintaining vigilance in validating these therapies potential long-term and sustainable mortality and morbidity gains
"Mensen hebben nauwelijks trek in voedsel waardoor ze in korte tijd spectaculair veel kunnen afvallen" Als GLP-1-receptoragonisten of semaglutide als afvalmiddel worden gebruikt, is het voordeel dat het inderdaad goed en snel werkt en dat mensen nauwelijks trek hebben in voedsel
Mass.: 11.28mg Avg
Lilly has not yet submitted for FDA approval, and industry estimates suggest a potential launch in 2028
This dual-action approach is designed to enhance weight loss by improving insulin secretion, reducing hunger, and potentially improving metabolic efficiency
78 These changes stabilize its structure, prevent protein degradation of the molecule in the circulation, and increase the circulation time enough to ensure once-daily injection (compared with exenatide, which is injected two or three times daily)
